AI takes on doctors in High-Stakes cancer diagnosis showdown
NCT ID NCT07307157
Summary
This study aims to see if an artificial intelligence (AI) system can diagnose specific types of brain, lung, and kidney cancer as accurately as human pathologists. Up to 25 experienced pathologists will review digital images of 300 patient samples, while the AI system analyzes the same images separately. The results will directly compare the accuracy of the human experts and the AI to help develop better diagnostic tools.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harvard Medical School
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.